GASTROINTESTINAL TUMOR
Clinical trials for GASTROINTESTINAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop Chemo-Induced bleeding risk in stomach and colon cancers
Disease control Recruiting nowThis phase 2 trial is testing whether the drug hetrombopag can prevent chemotherapy-induced thrombocytopenia (low platelet counts) in people with gastrointestinal tumors. The study will enroll 40 patients who had low platelets in a previous chemo cycle. Participants take hetrombo…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immune cells from your own tumor could fight stomach and bowel cancers
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy for people with advanced gastrointestinal tumors that have not responded to standard treatments. Doctors take immune cells from the patient's own tumor, grow them in a lab, and infuse them back after a short chemotherapy pr…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for Hard-to-Treat GI cancers? phase II trial launches
Disease control Recruiting nowThis phase II study is testing whether a new drug called SI-B003, alone or combined with BL-B01D1 or a PD-1 antibody, can shrink tumors in people with advanced esophageal, gastric, or colorectal cancer. About 376 participants will receive the treatments intravenously every three …
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug BL-B01D1 shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called BL-B01D1 in people with advanced stomach or other solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for any side effects. About 96 adults aged 18 to 75 will take part, and r…
Matched conditions: GASTROINTESTINAL TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC